What does Vectorite Biomedical Inc. do?

Vectorite Biomedical Inc. (4170.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4170.TWO's market cap?

Vectorite Biomedical Inc. (4170.TWO) has a market capitalization of approximately $555.9 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 4170.TWO pay a dividend?

No — Vectorite Biomedical Inc. (4170.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

4170.TWO

Vectorite Biomedical Inc.

TWO·Biotechnology · Healthcare

NT$12.70NT$0.00+0.00%

Market capNT$555.90M·Market closed·Aug 26 5:51 AM UTC

Price Chart

NT$12.70+NT$0.00 (+0.00%)today

+9.96%CAGR +1.92%

Select date range

FromTo

Apr 15, 2013Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

4170.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$54.81M

Net IncomeNT$118.19M

Net Margin215.6%

Operating Cash Flow−NT$4.76M

Capital ExpendituresNT$3.61M

Free Cash Flow−NT$8.37M

Return on Equity23.1%

Return on Invested Capital−1.5%

Net CashNT$166.02M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4170.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4170.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4170.TWO and 80,000+ other tickers.

About Vectorite Biomedical Inc.

Vectorite Biomedical Inc., established in 1993 and based in New Taipei City, Taiwan, is a biotechnology firm dedicated to research and development activities globally, including a strong presence in its home country. The company's operations encompass the manufacturing of specialized cell preparation products, in addition to providing full-spectrum services for the collection, processing, and secure storage management of immune cells. These advanced cellular preparations are vital for applications in the medical fields of infectious diseases, inflammatory conditions, and various oncological and tumor-related illnesses.

CEO: Kechang Ou
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 43
Website: www.vectorite.com.tw

Peers

Peers Tab

6549.TWO

TaiwanJ Pharmaceuticals Co., Ltd.

Cap

NT$532.8M

1781.TWO

Health & Life Co., Ltd.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4170.TWO

What does Vectorite Biomedical Inc. do?: Vectorite Biomedical Inc. (4170.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4170.TWO's market cap?: Vectorite Biomedical Inc. (4170.TWO) has a market capitalization of approximately $555.9 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 4170.TWO pay a dividend?: No — Vectorite Biomedical Inc. (4170.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.